{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-017476","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2024-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.137800+00:00","generated_at":"2026-06-06T15:50:03.763219+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aileron sets deadlines for shareholder proposals and director nominations for Feb 2024 annual meeting","bullets":["Annual meeting scheduled for February 28, 2024; no 2023 meeting was held.","Deadline for Rule 14a-8 stockholder proposals: January 29, 2024.","Deadline for director nominations under bylaws: February 8, 2024.","Submission address: 738 Main Street #398, Waltham, MA 02451."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-017476","json":"https://secwatch.observer/filing/0001193125-24-017476.json","markdown":"https://secwatch.observer/filing/0001193125-24-017476.md","text":"https://secwatch.observer/filing/0001193125-24-017476.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524017476/0001193125-24-017476-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524017476/d103474d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:50:03.763219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}